Hólyagrák: vizsgálatok itt: Svájc
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Bern, Geneva, Zurich
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Chur, Sankt Gallen, Winterthur
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisNot yet taking people in SvájcPrecise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
- Where
- Bern, Biel
- Életkor
- 18 év and over
- People
- 28
- Run by
- Hospital Centre Biel/Bienne
See details and how to joinNCT06227065 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Bellinzona, Chur, Sankt Gallen, Zurich
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 1/2. fázisNot yet taking people in SvájcFAPI PET Imaging - An Exploratory Study
- Where
- Baden, Geneva, Genolier, Lucerne, Zurich
- Életkor
- 18 év and over
- People
- 770
- Run by
- Martin Huellner
See details and how to joinNCT07705074 - 1. fázisTaking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Chur, Lausanne
- Életkor
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleT1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
- Where
- Basel, Lucerne
- Életkor
- 18 év and over
- People
- 35
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07581496 - No phaseTaking peopleEffects of Microbiological and Immunological Factors on the Lower Urinary Tract
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 800
- Run by
- University of Zurich
See details and how to joinNCT07494864 - 3. fázisTaking peopleThe Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
- Where
- Bern, Geneva, Lausanne, Rennaz
- Életkor
- 18 év and over
- People
- 232
- Run by
- Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT05726786 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Bern, Zurich
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767